Literature DB >> 9563141

Apoptosis in prostatic adenocarcinoma following complete androgen ablation.

R Montironi1, R Pomante, L Diamanti, C Magi-Galluzzi.   

Abstract

OBJECTIVE: To analyze the cell death phenomenon in prostate cancer following complete androgen ablation.
METHODS: The frequency and location of apoptotic bodies (ABs) were evaluated in haematoxylin and eosin stained sections of radical prostatectomy specimens from patients with invasive prostatic adenocarcinoma treated with neo-adjuvant endocrine combination therapy for 3 months before surgery. The results were compared with an untreated age- and stage-matched control group.
RESULTS: Both in treated and untreated prostate tissue the AB frequency increased from normal prostate, through prostatic intraepithelial neoplasia, up to prostatic adenocarcinoma. The main location was in the cell layers adjacent to the stroma, their frequency decreasing towards the lumen. The frequency of ABs was higher in the treated prostate glands than in the untreated groups. The relative increase of the AB frequency in treated carcinomas as compared with untreated ones was lowest in tumours with a solid pattern, intermediate in the cribriform, and highest in the acinar pattern.
CONCLUSIONS: Complete androgen ablation induces involution of prostate tissue mainly through the enhancement of apoptosis. This type of cell death is thought to play a major role and might be linked to specific changes in signal transduction mechanisms in response to hormonal withdrawal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563141     DOI: 10.1159/000056542

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

2.  T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer.

Authors:  M Mercader; B K Bodner; M T Moser; P S Kwon; E S Park; R G Manecke; T M Ellis; E M Wojcik; D Yang; R C Flanigan; W B Waters; W M Kast; E D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

Review 3.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

Review 4.  Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer.

Authors:  Siddhartha Das Pramanik; Amit Kumar Halder; Ushmita Mukherjee; Dharmendra Kumar; Yadu Nandan Dey; Mogana R
Journal:  Front Chem       Date:  2022-08-12       Impact factor: 5.545

5.  Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells.

Authors:  Tae-Jin Lee; Oliver Sartor; Ronald B Luftig; Shahriar Koochekpour
Journal:  Mol Cancer       Date:  2004-11-17       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.